Sanofi inks pact with Unitaid; to reduce TB drug Rifapentine price by 70%
Posted by
www.biotecnika.org
In a landmark development, global biopharmaceutical company Sanofi
will lower the price of Rifapentine, a critically important drug used
to prevent tuberculosis (TB), as part of the agreement with Unitaid,
the Global Fund to Fight AIDS, Tuberculosis and Malaria, an official
release said on Thursday.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sanofi-inks-pact-with-unitaid-to-reduce-tb-drug-rifapentine-price-by-70/articleshow/71836241.cms
Subscribe to:
Post Comments (Atom)
Post a Comment